In summary, our study revealed for the first time that the SPOCK1 expression is associated with advanced stages, larger tumor sizes, and lymph node/distal metastases, and it was identified as an independent predictive marker for poor prognoses in patients with ccRCC. This evidence concerns the gene SPOCK1 and nonpapillary renal cell carcinoma.